GSK3B and Alzheimer disease: In line with this evidence in an in vitro model of Alzheimer’s disease, CBD treatment suppressed the hyperphosphorylation of tau protein-mediated to β-catenin and GSK-3β, in Aβ-stimulated PC12 neuronal cells [111].